Find verified Lenvatinib Mesylate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Lenvatinib Mesylate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Lenvatinib Mesylate API.
Alternate Names: Lenvatinib Methanesulfonate, Lenvima
CAS No: 857890-39-2
PubChem CID: 11237762
Mol Formula: C22H23ClN4O7S
Mol Weight: 523.0 g/mol
IUPAC Name: 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;methanesulfonic acid
API Description: Lenvatinib mesylate is a methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine. It has a role as an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, a fibroblast growth factor receptor antagonist, an orphan drug, a vascular endothelial growth factor receptor antagonist and an antineoplastic agent. It contains a lenvatinib(1+).
